Profiling Prostate Cancer Therapeutic Resistance.

about

LncRNA TINCR is associated with clinical progression and serves as tumor suppressive role in prostate cancer

P2860

Q58735839-E653FF55-D7F8-4076-B60B-6863DF54B2E0

P2860

Profiling Prostate Cancer Therapeutic Resistance.

Item

http://www.wikidata.org/entity/Q52644478

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

Profiling Prostate Cancer Therapeutic Resistance.

@en

Profiling Prostate Cancer Therapeutic Resistance.

@nl

type

Item

label

Profiling Prostate Cancer Therapeutic Resistance.

@en

Profiling Prostate Cancer Therapeutic Resistance.

@nl

prefLabel

Profiling Prostate Cancer Therapeutic Resistance.

@en

Profiling Prostate Cancer Therapeutic Resistance.

@nl

P1476

Profiling Prostate Cancer Therapeutic Resistance.

@en

P2093

Cameron A Wade

http://www.w3.org/2001/XMLSchema#string

Natasha Kyprianou

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution

P2860

A novel mechanism for regulating transforming growth factor beta (TGF-beta) signaling. Functional modulation of type III TGF-beta receptor expression through interaction with the PDZ domain protein, GIPC

Male germ cell-associated kinase, a male-specific kinase regulated by androgen, is a coactivator of androgen receptor in prostate cancer cells

Aberrant expression of the transcription factors snail and slug alters the response to genotoxic stress

Transforming growth factor beta stabilizes p15INK4B protein, increases p15INK4B-cdk4 complexes, and inhibits cyclin D1-cdk4 association in human mammary epithelial cells

Unraveling insulin-like growth factor binding protein-3 actions in human disease

Prevalence of Prostate Cancer Clinical States and Mortality in the United States: Estimates Using a Dynamic Progression Model

Development of sipuleucel-T: autologous cellular immunotherapy for the treatment of metastatic castrate resistant prostate cancer

Innovation in metabolomics to improve personalized healthcare

Uncovering the roles of miRNAs and their relationship with androgen receptor in prostate cancer

Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer.

P31

scholarly article

review article

P356

10.3390/IJMS19030904

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P5008

ScienceSource

P577

2018-03-19T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29562686

http://www.w3.org/2001/XMLSchema#string

P921

prostate cancer

P932

5877765

http://www.w3.org/2001/XMLSchema#string

Profiling Prostate Cancer Therapeutic Resistance.

about

P2860

P2860

Profiling Prostate Cancer Therapeutic Resistance.

description

name

type

label

prefLabel

P1433

P1476

P2093

P275

P2860

P31

P356

P407

P433

P478

P5008

P577

P698

P921

P932

P356

P1433

P1476

P2093

P275

P2860

P31

P356

P407

P433

P478

P5008

P577

P698

P921

P932